Stocks of Sabra Healthcare REIT Inc (NASDAQ:SBRA) traded higher last session on Wall Street, up 0.49% to $18.34.
SBRA stock price is now 4.04% away from the 50-day moving average and 4.03% away from the 200-day moving average. The market capitalization of the company currently stands at $4.36B.
On January 07, 2025, JMP Securities Upgraded its previous ‘Mkt Perform’ rating to ‘Mkt Outperform’ on the stock keeping its target price maintained at $20, while ‘Mizuho’ rates the stock as ‘Neutral’
In other news, FOSTER MICHAEL J, Director sold 11,000 shares of the company’s stock on May 20 ’25. The stock was sold for $200,376 at an average price of $18.22. Upon completion of the transaction, the Director now directly owns 64,725 shares in the company, valued at $1.19 million. An SEC document containing details of the transaction can be found on the SEC’s website. On May 15 ’25, Director Michael J. Foster bought 11,000 shares of the business’s stock. A total of $192,500 was incurred on buying the stock at an average price of $17.50. A total of 1.84% of the company’s stock is owned by insiders.
During the past 12 months, Sabra Healthcare REIT Inc has had a low of $14.05 and a high of $19.99. As of last week, the company has a debt-to-equity ratio of 0.90, a current ratio of 0.25, and a quick ratio of 0.25.
The net profit margin was 19.70% and return on equity was 5.15% for SBRA. For the current quarter, analysts expect SBRA to generate $185.64M in revenue.
